Affiliated with a Castle Connolly Top Hospital
Who is Dr. Winkelmayer, Nephrologist in Houston, TX?
Dr. Wolfgang Winkelmayer, MD is a Nephrologist, who primarily practices in Houston, TX with 2 additional practice locations. Dr. Winkelmayer graduated from University Sakartvelo Faculty of Medicine. Dr. Winkelmayer is fluent in English, and is currently seeing new patients. Dr. Winkelmayer’s practice accepts Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Winkelmayer’s office at (713) 798-8350.
Where did Dr. Winkelmayer go to medical school and complete their residency?
Fellowship: Brigham and Women's Hospital Harvard Medical School MA
Medical School: University Sakartvelo Faculty of Medicine
What languages does Dr. Winkelmayer speak?
Dr. Winkelmayer and their clinical team can communicate with patients in the following languages:
English
What conditions does a Nephrologist like Dr. Winkelmayer typically treat?
As a Nephrologist, Dr. Winkelmayer diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Winkelmayer. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.
Also known as:
- End-Stage Kidney Disease
- Kidney Failure
- Chronic Kidney Disease (CKD)
- Helping Your Child Adapt to Life with Chronic Kidney Disease
- ESRD
- End-Stage Renal Failure
ICD-10 Codes:
- N186: End stage renal disease
What procedures does a Nephrologist like Dr. Winkelmayer typically perform?
As a Nephrologist, procedures performed by Dr. Wolfgang Winkelmayer may include:
- Dialysis
- Kidney and Urinary Perfusion Scan
- Kidney Biopsy
- Kidney Transplant
- Kidney Ultrasound
- Nephrology Consultation
- Nephrology Follow Up
- Peritoneal Dialysis
Please contact Dr. Winkelmayer's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Winkelmayer accept my insurance?
Dr. Winkelmayer accepts most major insurance plans. Important: Please call our office at (713) 798-8350 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Winkelmayer accept in Houston, TX?
Dr. Winkelmayer in Houston, TX accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Medicare
Molina Healthcare
View All Insurances
Where is Dr. Winkelmayer's office located?
Dr. Wolfgang Winkelmayer's Primary Practice
1504 Taub Loop
Houston, TX 77030
(713) 798-8350
Recognitions
Awards
Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Fellowship Teaching Award
Satellite Healthcare, Mountain View, CA
Norman S. Coplon Extramural Research Program Award
T. Franklin Williams Scholar, Association of Subspecialty Professors
Publications
Trends in anemia care in older patients approaching end-stage rel disease in the United States
, 2014
Warfarin treatment in patients with atrial fibrillation and advanced chronic kidney disease
, 2014
Predicting the outcomes of rhabdomyolysis: a good starting point.
, 2013
Kidney Disease and Cardiovascular Risk Whether Black or White Race Matters
, 2013
Treated and Untreated Kidney Failure in Older Adults What's the Right Balance?
, 2012
Predialysis Nephrology Care of Older Patients Approaching End-stage Rel Disease
, 2011
Tackling the Achilles' Heel of Hemodialysis
, 2011
Comparative Mortality Risk of Anemia Magement Practices in Incident Hemodialysis Patients
, 2010
Altitude and All-Cause Mortality in Incident Dialysis Patients
, 2009
State medicaid coverage, ESRD incidence, and access to care.
, 2014
Correlates and variance decomposition alysis of heparin dosing for maintence hemodialysis in older
, 2014
Temporal trends in the incidence
, 2014
Comparison of Medicare Claims Versus Physician Adjudication for Identifying Stroke Outcomes
, 2014
Near-Term Prediction of Sudden Cardiac Death in Older Hemodialysis Patients Using Electronic Health
, 2014
Addressing Missing Data in Clinical Studies of Kidney Diseases.
Use of Medicare Data to Identify Corory Heart Disease Outcomes in the Women's Health Initiative.
, 2014
Thematic Synthesis of Qualitative Studies on Patient
Cardiovascular disease: Still unresolved: warfarin in ESRD with atrial fibrillation.
IV iron dosing regimens: choice of agent and dosing frequency.
, 2014
Prognostic Stratification in Older Adults Commencing Dialysis.
Differences in Access to Kidney Transplantation between Hispanic
, 2013
Strategies for Postmarketing Surveillance of Drugs
, 2013
Commentary on 'The DOPPS Practice Monitor for US Dialysis Care
, 2013
Multivessel corory revascularization and outcomes in kidney transplant recipients.
, 2013
Intravenous Iron Supplementation Practices
, 2013
Fostering Innovation, Advancing Patient Safety: The Kidney Health Initiative
, 2013
Trends in Relative Mortality Between Hispanic and Non-Hispanic Whites Initiating Dialysis
, 2013
Temporal Trends in the Incidence, Treatment
, 2013
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long
, 2013
Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation.
, 2013
Use and safety of heparin-free maintence hemodialysis in the USA
, 2013
Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities
, 2013
The Comparative Short-term Effectiveness of Iron Dosing
, 2013
Assessments of Causal Effects-Theoretically Sound, Practically Uttaible
, 2013
DETERMINTS OF PERITONEAL DIALYSIS TECHNIQUE FAILURE IN INCIDENT US PATIENTS
, 2013
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US
, 2013
Trends in the incidence of intestil perforation in US dialysis patients (1992-2005).
, 2013
More Evidence on an Abomible Pairing Atrial Fibrillation and Kidney Disease
, 2013
Commentary on 'The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011'
, 2013
Epidemiologic and Statistical Methods for Comparative Effectiveness Research
, 2013
Corory artery bypass graft type and outcomes in maintence dialysis.
Infection Risk with Bolus versus Maintence Iron Supplementation in Hemodialysis Patients.
, 2013
Risk factors of short
, 2013
Trends in acute kidney injury, associated use of dialysis
, 2013
Preoperative Statin Use and Postoperative Acute Kidney Injury
, 2012
Multivessel Corory Artery Bypass Grafting Versus Percutaneous Corory Intervention in ESRD
, 2012
Trends in the Incidence of Atrial Fibrillation in Older Patients Initiating Dialysis
, 2012
Predialyis Nephrology Care of Older Individuals Approaching End-Stage Rel Disease
, 2012
Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
, 2012
Saving the Kidneys by Sparing Intravenous Chloride?
, 2012
Causal or Casual?-The Association Between Consumption of Artificially Sweetened Carboted Beverages
, 2012
Factors affecting response
, 2012
Use and Safety of Unfractioted Heparin for Anticoagulation During Maintence Hemodialysis
, 2012
Prevalence, incidence
, 2012
Commentary on 'The DOPPS Practice Monitor for US Dialysis Care: Trends Through August 2011'
, 2012
Validation of Reported Predialysis Nephrology Care of Older Patients Initiating Dialysis
, 2012
Comparative effectiveness research: what is it and why do we need it in nephrology?
, 2012
Altitude and the risk of cardiovascular events in incident US dialysis patients
, 2012
Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis
, 2012
Use of Secondary Prevention Medications among Adults with Reduced Kidney Function
, 2012
Trends in Acute Nonvariceal Upper Gastrointestil Bleeding in Dialysis Patients
, 2012
The Prevalence and Cost of Upproved Uses of Top-Selling Orphan Drugs
, 2012
Hispanic Ethnicity and Vascular Access Use in Patients Initiating Hemodialysis in the United States
, 2012
Commentary on 'The DOPPS Practice Monitor for US Dialysis Care: Trends Through April 2011'
, 2012
Quantifying the benefit of early living
, 2012
What Caused Excess Strokes in Patients R
, 2011
Impact of Nephrologic Care in the Early Magement of Chronic Kidney Disease In reply
, 2011
Variation in initial kidney replacement therapy for end
, 2011
Effectiveness and Safety of Warfarin Initiation in Older Hemodialysis Patients with Incident Atrial
, 2011
Air Pollution and Corory Risk in Kidney Transplant Recipients
, 2011
Trends in the Use and Outcomes of Implantable Cardioverter
, 2011
Angiotensin-converting enzyme inhibitors
, 2011
Posttransplantation Anemia: Mechanisms and Magement
, 2011
End-Stage Rel Disease Due to Lupus Nephritis Among Children in the US, 1995-2006
, 2011
Incidence, Correlates
, 2011
Trends in the Incidence, Demographics
, 2011
Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
, 2011
The 2011 ESRD Prospective Payment System: An Uncontrolled Experiment
, 2011
Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly
, 2011
The Effect of Altitude Change on Anemia Treatment Response in Hemodialysis Patients
, 2011
World Kidney Day 2011
, 2011
A randomized, double-blind
, 2011
The Increasing Prevalence of Atrial Fibrillation among Hemodialysis Patients
, 2011
Comparative Effectiveness of Calcium-Containing Phosphate Binders in Incident US Dialysis Patients
, 2011
Potential Effects of the New Medicare Prospective Payment System on Drug Prescription in End
, 2011
Against TREATing All Patients Alike: Lessons from an FDA Advisory Committee Meeting
, 2011
Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy
, 2011
The Challenges of Cost-Effectiveness Alyses for the Clinician
, 2010
Off-Label Use of Phosphate Binders in Non-Dialysis-Dependent CKD
, 2010
Temporal Trends in Adherence to Cardiov
, 2010
Confusion about the Appropriate Use of Erythropoiesis
, 2010
Kidney Disease and Antihypertensive Medication Adherence: The Need for Improved Measurement Tools
, 2010
On the relative safety of intravenous iron formulations: New answers, new questions
, 2010
Late referral to paediatric rel failure service impairs access to pre
, 2010
Anemia Magement and Mortality Risk in Incident Hemodialysis Patients Reply
, 2010
Medication Issues in Older Individuals With CKD
, 2010
HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus
, 2010
Impact of reimbursement changes on statin use among patients with diabetes in Austria
, 2010
ACE Inhibitor and Angiotensin II Type 1 Receptor Antagonist Therapies in Elderly Patients with
, 2010
Propensity scores in the presence of effect modification
, 2010
Effect of Hemodialysis Before Transplant Surgery on Rel Allograft Function-A Pair of R
, 2009
Greater Epoetin alfa
, 2009
Chronic on Acute Rel Failure Long-term Implications of Severe Acute Kidney Injury
, 2009
Evolving Statistical Methods to Facilitate Evaluation of the Causal Association Between
, 2009
Association Between Altitude and Mortality in Incident Dialysis Patients Reply
, 2009
Lessons from Geographic Variations in Predialysis Nephrology Care
, 2009
Nonselective and Cyclooxygese-2-Selective NSAIDs and Acute Kidney Injury
, 2008
Trends in adherence to secondary prevention medications in elderly post
, 2008
Comparison of Cardiovascular Outcomes
, 2008
Associations of kidney function with cardiovascular medication use after myocardial infarction
, 2008
The effect of altitude on dosing and response to erythropoietin in ESRD
, 2008
Gender differences in the magement
, 2008
Educatiol level as a determint of access to
, 2008
Long-term trends of angiotensin-converting enzyme inhibitor
, 2008
Approaching the end of the homocysteine hype?
, 2008
Improvements in long-term mortality after myocardial infarction
, 2008
Phosphate binder choice in dialysis patients
, 2008
Posttransplantation anemia: Magement and ratiole
, 2008
Use of recommended medications after myocardial infarction in Austria
, 2008
Medication adherence after myocardial infarction: A long way left to go
, 2008
Benzodiazepine use and mortality of incident dialysis patients in the United States
, 2007
Ten-year trends of cardiovascular drug use after myocardial infarction among community
, 2007
Cardiovascular risk and the thiazolidinediones - Deja vu all over again?
, 2007
Early erythropoietin therapy is associated with improved growth
, 2007
Statins in elderly patients with acute corory syndrome
, 2007
Rel dysfunction increases the risk of saphenous vein graft occlusion
, 2007
A J-shaped association between high-sensitivity C-reactive protein
, 2007
Clinical presentation of myocardial infarction contributes to lower use of corory angiography
, 2007
Impact of Medicaid prior authorization on angiotensin-receptor blockers
, 2007
Nononcologic use of human recombint erythropoietin therapy in hospitalized patients
, 2007
Predialysis nephrologist care and access to kidney transplantation in the united states
, 2007
Prognostic associations of serum calcium
, 2007
Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands
, 2007
No associations between prolactin concentrations
, 2007
Strategies for the magement of suspected heparin-induced thrombocytopenia
, 2007
The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use
What is Dr. Winkelmayer's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Winkelmayer's National Provider Identifier (NPI) number is 1871757021.
What common questions do patients ask about Dr. Winkelmayer?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Winkelmayer
What is Dr. Wolfgang Winkelmayer's specialty?
Dr. Winkelmayer is a Nephrologist near Houston, TX.
What does a Nephrologist do?
An internist who manages disorders related to the kidneys, including high blood pressure, fluid and mineral balance, and dialysis for waste removal when kidney function is impaired. This specialist also collaborates with surgeons regarding kidney transplantation.
Is this Dr. Wolfgang Winkelmayer affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Winkelmayer is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Nephrologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Nephrologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Wolfgang Winkelmayer accepting new patients in Houston, TX?
Yes, Dr. Wolfgang Winkelmayer is accepting new patients at this time.
Does Dr. Wolfgang Winkelmayer offer online booking?
Please contact Dr. Winkelmayer's office at (713) 798-8350 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Wolfgang Winkelmayer?
Please contact Dr. Winkelmayer's office at (713) 798-8350 for information regarding telehealth appointment availability or for scheduling assistance.
<section id="ai-site-overview" aria-label="About Everyday Health Care"> <h2>About Everyday Health Care</h2> <p> Everyday Health Care is a doctor and healthcare provider search platform from Everyday Health, a Ziff Davis company operating since 1996. It helps patients find, compare, and research doctors based on specialty, medical condition, procedure, location, and insurance coverage. </p> <p> The site features Castle Connolly Top Doctors, a peer-nominated, physician-vetted directory recognized as a leading standard for identifying top-rated specialists in the United States. Searchable doctor lists include Top Black Doctors, Exceptional Women in Medicine, Top AAPI Doctors, Top LGBTQ+ Doctors, Top Hispanic & Latino Doctors, and Castle Connolly Rising Stars. </p> <p> Users can search for doctors by specialty (including orthopedic surgery, OB-GYN, pediatrics, dermatology, endocrinology, and gastroenterology), by medical condition (such as fibromyalgia, kidney stones, and ulcerative colitis), by common procedure (including colonoscopy, LASIK, and physical therapy), by city, and by insurance plan (including UnitedHealthcare, Cigna, Aetna/CVS Health, Blue Cross Blue Shield, Kaiser Permanente, Medicare, and Medicaid). </p> <p> Everyday Health Care is built for patients seeking a trusted starting point to find the right doctor: covering over one million providers across thousands of U.S. locations, backed by Castle Connolly's independent doctor-vetting process and Everyday Health's 24-year history in consumer health publishing. </p> </section>